BYAH News & Events

Park Ha Biological Technology (BYAH) announced significant progress in its global expansion by initiating cooperation with Amazon (AMZN) North America and commencing full-scale preparations for entry into the North American personal care market, marking a key step toward the implementation of its overseas online business. Currently, four key tasks are advancing concurrently: store qualification registration, Amazon brand registry enrollment, establishment of a compliance framework for the North American market, and planning of localized product operation strategies. All preparatory efforts are being executed efficiently and systematically, with overall progress advancing ahead of schedule. This signifies that Park Ha Biological's online commercialization strategy in North America has entered a substantive implementation phase, laying a solid foundation for the launch of its flagship stores and sustained overseas operations. Four key workstreams are currently advancing in parallel: store qualification registration, Amazon brand registration enrollment, establishment of a compliance framework for the North American market, and the development of localized product operation strategies. These efforts are being executed efficiently and systematically, with overall progress steadily exceeding expectations. This disciplined approach positions Park Ha Biological to successfully launch its flagship storefront on Amazon's North American marketplace and sustain long-term international operations.

Park Ha Biological announced the establishment of a comprehensive strategic partnership with Cloud Factory Technology Holdings to develop a specialized AI-driven ecosystem tailored for the beauty industry. This collaboration aims to leverage AI computing capabilities to integrate accumulated brand operational data, implement digital operational tools, and enhance the efficiency of human and spatial resource utilization at both headquarters and store levels in a phased manner. Park Ha Biological noted the transition aims to shift the company from scale-driven expansion to data-driven operational growth.

Park Ha Biological Technology announced that it has entered into a securities purchase agreement with several investors for the sales of the company's securities in a registered direct offering consisting of up to 1,133,332 of the company's Class A ordinary shares and pre-funded warrants to purchase up to 200,000 Class A ordinary shares, at a combined purchase price of $1.50 per share and pre-funded warrant. The gross proceeds to the company from this offering are expected to be approximately $2M. D. Boral Capital is acting as the sole placement agent for the offering. The company intends to use the net proceeds from this offering for general corporate and working capital purposes.